In 2025, the Food Standards Australia New Zealand (FSANZ) maintained a steady pace in the approval of food ingredients. CIRS Group conducted a statistical review of the 2025 submissions in Australia and New Zealand, aiming to provide data references and trend insights for companies planning to enter the ANZ market.

Overview of Food Ingredient Submissions in Australia and New Zealand in 2025
According to publicly available information on the FSANZ official website, the submission data for food substances in Australia and New Zealand in 2025 are as follows:
- 16 substances accepted for assessment,
- 11 public consultations, and
- 19 approved substances.
Special note: In 2025, a total of three substances submitted by Chinese companies were accepted for assessment, two entered the public consultation, and one has been officially approved.
Substances Accepted for Assessment in Australia and New Zealand in 2025 (16 items)
|
No. |
Application No. |
Substance Name |
Applicant |
Accepted Date |
|
1 |
A1321 |
Acetolactate decarboxylase from GM Bacillus licheniformis as a processing aid |
Novozymes Australia Pty Ltd |
2025.01.03 |
|
2 |
A1322 |
Extension of use of polyglycerol esters of interesterified ricinoleic acid in sauces and toppings |
Unilever Australia Limited |
2025.01.30 |
|
3 |
A1324 |
3-fucosyllactose as a nutritive substance in infant formula products |
Glycom A/S |
2025.02.11 |
|
4 |
A1325 |
Extension of use of steviol glycosides in hotplate flour products |
George Weston Foods Limited |
2025.03.04 |
|
5 |
A1326 |
Addition of phytosterols, phytostanols or their esters as a novel food to bread and bread products |
George Weston Foods Limited trading as Tip Top Bakeries |
2025.3.19 |
|
6 |
A1328 |
Danisco Australia IFF |
2025.03.26 |
|
|
7 |
A1333 |
Food derived from purple tomato lines containing event Del/Ros1-N |
Norfolk Healthy Produce |
2025.06.20 |
|
8 |
A1332 |
Cross-linked polyester resins as an adsorbent processing aid in wine |
Amaea Limited |
2025.07.09 |
|
9 |
A1334 |
Cataya Bio (Shanghai) Company Limited (China) |
2025.07.22 |
|
|
10 |
A1336 |
2′-FL from GM Escherichia coli BL21 in infant formula products |
Synaura Biotechnology (Shanghai) Co., Ltd (China) |
2025.08.13 |
|
11 |
A1338 |
Chr. Hansen Pty Ltd |
2025.09.16 |
|
|
12 |
A1340 |
Suzhou Yixi Biotech Co., Ltd. (China) |
2025.09.23 |
|
|
13 |
A1339 |
Chr. Hansen A/S |
2025.10.02 |
|
|
14 |
A1341 |
Cell-cultured duck (Anas platyrhynchos domesticus) biomass as a food ingredient |
Suprême SAS (Gourmey) |
2025.10.16 |
|
15 |
A1342 |
Beta-casein protein preparation (BCPP1) from GM Komagataella phaffii |
Eden Brew Pty Ltd |
2025.11.25 |
|
16 |
A1345 |
IFF Health & Biosciences |
2025.12.18 |
Substances under Public Consultation in Australia and New Zealand in 2025 (11 items)
|
No. |
Application No. |
Substance Name |
Applicant |
Public Consultation Period |
|
1 |
A1310 |
Bayer CropScience Pty Ltd |
2025.01.07-2025.02.18 |
|
|
2 |
A1323 |
Corteva Agriscience Australia Pty Ltd |
2025.03.04-2025.04.15 |
|
|
3 |
A1315 |
Chitosan and (1,3)-beta-glucans from white button mushrooms (Agaricus bisporus) as a food additive |
Chinova Bioworks Inc |
2025.03.25-2025.05.06 |
|
4 |
A1318 |
Sichuan Ingia Biosynthetic Co., Ltd. (China) |
2025.04.08-2025.05.20 |
|
|
5 |
A1288 |
Thermolysin from Anoxybacillus caldiproteolyticus Rokko as a processing aid |
IFF Australia Pty Ltd |
2025.05.22-2025.07.03 |
|
6 |
A1324 |
3-fucosyllactose as a nutritive substance in infant formula products |
Glycom A/S |
2025.06.11-2025.07.23 |
|
7 |
A1292 |
Phospholipase C from Bacillus licheniformis as a processing aid |
Novozymes Japan Ltd |
2025.07.15-2025.08.26 |
|
8 |
A1333 |
Food derived from purple tomato lines containing event Del/Ros1-N |
Norfolk Healthy Produce |
2025.07.30-2025.09.10 |
|
9 |
A1293 |
Phospholipase C from Bacillus licheniformis as a processing aid |
Novozymes Japan Ltd |
2025.09.02-2025.09.30 |
|
10 |
A1334 |
Cataya Bio (Shanghai) Company Limited(China) |
2025.10.21-2025.11.18 |
|
|
11 |
A1304 |
Novozymes Australia Pty Ltd |
2025.12.11-2026.01.29 |
Substances Approved in Australia and New Zealand in 2025 (19 items)
|
No. |
Application No. |
Substance Name |
Applicant |
Approved Date |
|
1 |
A1299 |
Fructosyltransferase from Aspergillus oryzae as a processing aid |
Tate and Lyle Solutions USA LLC |
2025.02.14 |
|
2 |
A1301 |
Triacylglycerol lipase from GM Komagataella phaffii as a processing aid |
Danstar Ferment AG |
2025.02.14 |
|
3 |
A1303 |
Food derived from herbicide-tolerant sugar beet line KWS20-1 |
Bayer CropScience Pty Ltd |
2025.02.14 |
|
4 |
A1302 |
Syngenta Pty Ltd |
2025.03.26 |
|
|
5 |
A1269 |
Vow Group Pty Ltd |
2025.04.07 |
|
|
6 |
A1279 |
Lentinula edodes (Shiitake mushroom) mycelia as a processing aid |
MycoTechnology, Inc. |
2025.05.14 |
|
7 |
A1307 |
Milk fat globule membrane as a nutritive substance in infant formula products |
Arla Foods Ingredients Group P/S |
2025.05.14 |
|
8 |
A1308 |
Kyowa Hakko Bio Co., Ltd |
2025.05.14 |
|
|
9 |
A1310 |
Bayer CropScience Pty Ltd |
2025.05.14 |
|
|
10 |
A1311 |
Prolyl oligopeptidase from GM Trichoderma reesei as a processing aid |
Bayer CropScience Pty Ltd. |
2025.05.14 |
|
11 |
A1323 |
Corteva Agriscience Australia Pty Ltd |
2025.06.18 |
|
|
12 |
A1315 |
Chitosan and (1,3)-beta-glucans from white button mushrooms (Agaricus bisporus) as a food additive |
Chinova Bioworks Inc |
2025.07.03 |
|
13 |
A1318 |
Sichuan Ingia Biosynthetic Co., Ltd.(China) |
2025.08.14 |
|
|
14 |
A1288 |
Thermolysin from Anoxybacillus caldiproteolyticus Rokko as a processing aid |
IFF Australia Pty Ltd |
2025.09.25 |
|
15 |
A1324 |
3-fucosyllactose as a nutritive substance in infant formula products |
Glycom A/S |
2025.11.10 |
|
16 |
A1333 |
Food derived from purple tomato lines containing event Del/Ros1-N |
Norfolk Healthy Produce |
2025.11.10 |
|
17 |
A1292 |
Phospholipase C from Bacillus licheniformis as a processing aid |
Novozymes Japan Ltd |
2025.12.18 |
|
18 |
A1293 |
Phosphoinositide PLC from Bacillus licheniformis as a processing aid |
Novozymes Japan Ltd |
2025.12.18 |
|
19 |
A1328 |
Danisco Australia IFF |
2025.12.18 |
Summary
The 2025 submission trends in Australia and New Zealand clearly indicate that microbial manufacturing and genetic modification technologies have become the dominant driving forces in R&D. From the continued popularity of human milk oligosaccharides to diverse enzyme preparations and emerging mycelial biomass, the technological boundaries are continually expanding. Notably, Chinese biotechnology companies, leveraging their early advantages in synthetic biology, are demonstrating strong innovation capacity and competitiveness in the global market. As regulatory requirements continue to rise, accurately understanding market entry timelines and achieving efficient compliance submissions has become the “golden key” for companies seeking to capture a share of the global high-value ingredient market.
Notes
- The data in this article are sourced from the public search platform of the Food Standards Australia New Zealand official website.
- The statistical data are collected up to December 31, 2025.
- The statistics include only applications submitted by companies for food-related substances, and do not include non-food substances or proposals initiated by authorities themselves.
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.